Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Ribon Therapeutics
99 Hayden Avenue, Building D, Suite 100
Lexington, MA 02421
Phone: 617-914-8700

Ribon Therapeutics is a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease. We are exploring novel areas of biology to develop effective treatments for patients with limited therapeutic options. Leveraging a chemical biology approach and our proprietary discovery platform, we are building a pipeline of selective, small molecule inhibitors to numerous NAD+ utilizing enzymes, beginning with monoPARPs, which have applications across multiple therapeutic areas. Our lead program is developing PARP7 inhibitors for the treatment of cancer.

Key Contact
Name
Victoria Richon
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/04/19 $65,000,000 Series B Celgene Corporation
Deerfield Management Company, L.P.
Johnson & Johnson Development Corporation (JJDC)
Novartis Venture Funds
Osage University Partners
Takeda Ventures
The Column Group
US Venture Partners
undisclosed